Nevada 2025 Regular Session

Nevada Senate Bill SB217

Introduced
2/19/25  
Refer
2/19/25  
Report Pass
4/18/25  

Caption

Makes revisions relating to reproductive health care. (BDR 40-24)

Impact

The legislation mandates that health insurers must provide specific coverage for infertility treatments and allow for special enrollment periods for pregnant individuals, ensuring they can access insurance during critical times without penalties. Additionally, public health programs such as Medicaid are required to cover related treatments under defined conditions, which could significantly improve accessibility to reproductive health services for underserved populations. The bill underscores a shift towards comprehensive support for reproductive health within state law, emphasizing both patient rights and health care provider responsibilities.

Summary

Senate Bill 217 (SB217) seeks to enhance protections and access related to assisted reproduction and infertility treatments within the state of Nevada. The bill prohibits governmental entities from enacting restrictions that substantially burden access to assisted reproduction, related drugs, or information. It establishes a legal framework whereby individuals can assert claims if their rights under this bill are infringed upon, allowing for potential damages and relief in court. Furthermore, SB217 delineates that a fertilized egg or embryo prior to implantation is not legally considered a person, which may affect future legal interpretations regarding reproductive rights.

Sentiment

The general sentiment surrounding SB217 appears to be supportive among reproductive health advocates and healthcare providers, who view it as a necessary step toward enhancing reproductive rights and access. However, there are concerns raised by certain opposition groups pertaining to the broader implications of defining embryos legally, which might influence future discussions around reproductive rights and personhood issues. Indeed, the bill has spurred significant public discourse regarding the balance between state regulation and individual reproductive freedoms.

Contention

Key points of contention include the implications of defining embryos and the potential for government overreach in personal health decisions. Some critics argue that the bill's provisions could lead to unintended consequences in regulatory areas not directly related to assisted reproduction. Furthermore, while the bill aims to remove barriers to assisted reproduction, there is debate about whether it sufficiently protects against discrimination based on reproductive choices and genetic conditions, highlighting the need for ongoing dialogue within legislative discussions.

Companion Bills

No companion bills found.

Similar Bills

NJ A4027

Requires health insurance coverage of preimplantation genetic testing with in vitro fertilization under certain conditions.

RI S0691

Requires individual and group health insurance policies that provide pregnancy-related benefits to cover medically necessary expenses for diagnosis and treatment of infertility and standard fertility-preservation services.

RI H5629

Amends the current law on health insurance coverage for fertility diagnostic care, standard fertility preservation services, and fertility treatment and requires coverage for any medically necessary ovulation-enhancing drugs and medical services.

IA SF130

A bill for an act relating to health insurance coverage for infertility.

OR HB2959

Relating to infertility; declaring an emergency.

OR SB535

Relating to infertility; declaring an emergency.

NV AB428

Requires certain health plans to include coverage for fertility preservation services. (BDR 57-915)

NJ S3831

Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.